Suggestions
Steve Miller
Senior Director at Marinus Pharma with a background in Neuroscience
Steve Miller, Ph.D. is the Principal Owner of Elite Performance Solutions Inc, a company based in the San Francisco Bay Area.1 He has been in this role since August 2020. Elite Performance Solutions, also known as Applied Neuroscience Solutions, focuses on developing products and services that utilize biosensor technology, particularly EEG, to enhance human performance, learning, and overall brain wellness.1
Professional Background
Dr. Miller has over 20 years of academic and industry experience.1 His career highlights include:
-
Owner of Nelson Miller Group (October 2016 - Present): A contract research organization specializing in applied neuroscience and advanced learning technologies.1
-
Executive Vice President at Platypus Institute (May 2017 - February 2020): Based in the Greater San Diego Area.1
-
Chief Scientist at Nervanix (2014 - 2016): Worked on applying neuroscience advances to improve learning models and cognitive skills development.1
-
Co-Founder and Chief Scientist at Scientific Learning (March 1996 - May 2009): Helped establish a K12 education software company based on the neuroscience of learning.1
Academic Experience
Dr. Miller has also held several academic positions:
-
Research Associate Professor at Rutgers University (1994 - 1996): Worked as a Principal Investigator on various grants related to brain-based disorders.1
-
Visiting Scientist at New York University School of Medicine (1994 - 1996): Conducted basic studies using MEG, fMRI, and MRI.1
-
Postdoctoral Fellowship at Rutgers University (1991 - 1993): Focused on developmental disorders including dyslexia.1
Education
Steve Miller holds a Ph.D., though the specific field and institution are not mentioned in the provided search results. He also has a Master's degree in Neuroscience/Experimental Psychology from the University of Hartford (1985 - 1987).1
Highlights
Neurological Conditions Now the Leading Cause of Disability Worldwide, Affecting 3.4 Billion People
A comprehensive new analysis from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021, published in The Lancet Neurology, reveals that neurological conditions have become the top contributor to the global disease burden, surpassing cardiovascular diseases.
Key findings include: In 2021, neurological conditions affected 43% of the world's population (3.4 billion individuals). These conditions were responsible for 443 million years of healthy life lost due to illness, disability, and premature death (disability-adjusted life years or DALYs). The top contributors to neurological health loss globally were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, and diabetic neuropathy. Neurodevelopmental and pediatric conditions accounted for almost a fifth of the total neurological burden worldwide. Over 80% of neurological deaths and health loss occurred in low- and middle-income countries. Modifying risk factors, such as high blood pressure, could significantly reduce the burden of some neurological conditions.
The authors emphasize the urgent need to make neurological health a global public health priority, calling for targeted interventions, increased investment in research, and improved access to prevention, treatment, rehabilitation, and long-term care strategies. For more information, read the full article: https://lnkd.in/gY5jysv3.
This update summarizes some of the key points from the article, highlighting the global impact of neurological conditions and the need for action. Infographic: https://lnkd.in/gbv3rPTF
https://lnkd.in/gY5jysv3.
I’m happy to share that I’ve obtained a new certification: Online CPR/AED and First Aid Combo Course from (ISSA) International Sports Sciences Association!
